Pocket Emergency Medicine (Pocket Notebook Series) 3rd Ed.

DRUGS OF ABUSE

BENZODIAZEPINES

Definition

• GABA agonists

History

• Usually suicidal gesture or abuse, hypnotic/sleep agents (zaleplon, zolpidem, eszopiclone) have similar effects as BZD in overdose

Physical Findings

• CNS, respiratory depression, slurred speech, ataxia, hyporeflexia, midpoint/small pupils, hypothermia, hypotension

Evaluation

• Glucose, ABG, Serum/urine tox screen, end-tidal CO2 monitor, Tele, pulse ox

Treatment

• Supportive (airway protection if needed), Flumazenil 0.1–0.2 mg, repeat up to 3 mg → may precipitate szs, indications are rare, use only to reverse when known benzo is overadministered as part of procedural sedation & must be reversed for life-threatening sxs, monitor for resedation after 1–2 h, may require repeat dose

• Decontamination: Activated charcoal if ingestion occurred w/i 30 min

Disposition

• Home (rarely require admission) if resolution of symptoms after a period of monitoring

Pearls

• Monitor for withdrawal, which is similar in presentation (agitation, szs) & tx to EtOH withdrawal

• Isolated benzo OD rarely life-threatening although usually presents as combination OD

GAMMA-HYDROXYBUTYRATE (GHB)

Definition

• GABA & GHB receptor agonist

Physical Findings

• Initial euphoria, CNS/obtundation, hypothermia, bradycardia, hypotension, sz, respiratory depression, myoclonus, aspiration, rarely pulmonary edema & sz

Evaluation

• Serum/urine tox screen (rapidly metabolized → GHB levels not readily available)

Treatment

• Supportive, maintain airway, recovery w/i 2–4 h, resolution w/i 8 h

Disposition

• Home

OPIATES

Definition

• Opiate receptor agonist

History

• Witnessed or reported use of opiates (heroin, methadone, morphine, hydromorphone, fentanyl, oxycodone)

Physical Findings

• ↓ CNS, ↓ RR/BP, apnea, ± miosis, track marks, aspiration, noncardiogenic pulmonary edema

Evaluation

• Glucose, serum/urine tox screen (for coingestants), end-tidal CO2 monitor, Tele, pulse ox

Treatment

• Maintain airway

• Naloxone (titrate to effect) 0.2–0.4 mg IV → 1 mg IV → 2 mg IV → IV drip (duration 1–2 h)

• Activated charcoal (recent ingestion), whole bowel irrigation (long-acting opioid)

Disposition

• May require admission for long-acting opiates

Pearls

Pts die from untreated apnea, often in prehospital setting

• Pts w/ hypoxia/cyanosis have risk of aspiration/ARDS

• Pts w/ recurrent apnea after naloxone likely have longer-acting opiate

Opiate Withdrawal

Definition

• Cessation or rapid reduction of opiate use in a dependent individual

History

• Chronic opiate use, anxiety, nausea, vomiting, abdominal pain, diarrhea, myalgias

Physical Findings

• Yawning, rhinorrhea, mydriasis, piloerection, tachycardia

Treatment

• Clonidine 0.1 mg PO q30–60min (central α-agonist) → ↓ duration, methadone (not indicated in the ED)

Disposition

• Home or detox

Pearl

• Not life-threatening, do not require admission, may be precipitated by administration of naloxone & caution should be used before treating w/ additional opiate

COCAINE

Definition

• Snorting, injecting, smoking, ingesting (body packers) cocaine (peak 5–15 min, duration 1–4 h, releases norepinephrine/blocks reuptake)

History

• Cocaine use, anxiety, CP, focal weakness (CVA/ICH), sz, psychosis

Physical Findings

• ↑ HR, ↑ BP, hyperthermia, diaphoresis, agitation, nasal septal perforation

Evaluation

• Serum/urine tox screen, cardiac markers (if CP present), ECG (↑ QRS, ischemia), Cr (renal failure), CK (rhabdomyolysis), head CT (if ICH suspected), consider aortic dissection, intestinal infarction, stroke

Treatment

• Supportive care, BZD for anxiety/agitation/CP, treat hyperthermia (ice packs, cooling blankets, cooling mist), avoid βBs (unopposed α-adrenergic stimulation)

• Activated charcoal (recent ingestion), whole bowel irrigation (packers/stuffers)

Disposition

• Varies depending on existing cx of cocaine abuse

Pearl

• Cocaine wash-out syndrome: After cocaine binging, MS (lethargy, obtundation), lasts up to 24 h

METHAMPHETAMINE (“METH”)

Definition

• Norepinephrine release, dopaminergic (causes addiction)

History

• Ingestion, snorting, smoking, injection, rectal insertion of methamphetamines & derivatives (LSD, bath salts), ADHD, & narcolepsy medications

Physical Findings

• ↑ HR, ↑ BP, hyperthermia, diaphoresis, agitation, poor dentition (“meth mouth”), poor hygiene, compulsive scratching lesions (“meth mites”), tremors, sz

Evaluation

• Serum/urine tox screen, ECG, consider CT head (ICH), UA, CK (rhabdomyolysis), chemistries, cardiac enzymes (CP), Tele

Treatment

• Supportive care, BZD for anxiety/agitation/CP, cool hyperthermic pts (ice packs, cooling blankets, cooling mist)

• Activated charcoal (recent ingestion), whole bowel irrigation (packers/stuffers)

METHYLENEDIOXYMETHAMPHETAMINE (MDMA, “ECSTASY”), LYSERGIC ACID DIETHYLAMIDE (LSD)

Definition

• Serotonergic

History

• Ingestion MDMA, LSD, other hallucinogens

Physical Findings

• ↑ HR, ↑ BP, hyperthermia, anxiety, mydriasis, hallucinations, sz, diaphoresis, bruxism

Evaluation

• Serum/urine tox screen, chemistries (↓ Na due to excessive water ingestion), ECG, consider CT head (ICH), INR, UA, CK (rhabdomyolysis), cardiac enzymes (CP), Tele

Treatment

• Supportive care, BZD & haloperidol for agitation, cool hyperthermic pts (ice packs, cooling blankets, cooling mist)

• Activated charcoal (recent ingestion)



If you find an error or have any questions, please email us at admin@doctorlib.org. Thank you!